Nariaki Asada
Hamburg, HH 20246, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Low-dose glucocorticoids attenuate crescentic glomerulonephritis by inhibiting the local differentiation of proinflammatory neutrophils.
Journal: Science translational medicine
Published: October 15, 2025
Miniproteins may have a big impact: new therapeutics for autoimmune diseases and beyond.
Journal: Signal transduction and targeted therapy
Published: September 11, 2024
S1PR1 mediates Th17 cell migration from the thymus to the skin in health and disease.
Journal: Frontiers in immunology
Published: July 30, 2024
Targeting T cell plasticity in kidney and gut inflammation by pooled single-cell CRISPR screening.
Journal: Science immunology
Published: June 14, 2024
Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in mice.
Journal: Nature communications
Published: June 11, 2024
The RNA binding protein Arid5a drives IL-17-dependent autoantibody-induced glomerulonephritis.
Journal: The Journal of experimental medicine
Published: April 12, 2024
C/EBPδ Mediates Immunity to Renal Autoinflammatory Disorders in a Stage-specific Manner.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 05, 2024
Targeting Monocyte Derived CCL17 Attenuates Murine Crescentic Glomerulonephritis by Affecting Renal CCR4+ Regulatory T-Cell Recruitment.
Journal: American journal of nephrology
Published: July 26, 2023
CD4+ T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12.
Journal: Science translational medicine
Published: March 15, 2023
Tissue-resident memory T cells in renal autoimmune diseases.
Journal: Frontiers in immunology
Published: November 29, 2022
Last Updated: 09/26/2026